Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: ERN, ERP

Veritiv Announces Record Second Quarter 2022 Net Income, EPS, Adjusted EBITDA, and Adjusted EBITDA Margin; Raises Earnings Guidance


Second Quarter Financial Highlights

ATLANTA, Aug. 9, 2022 /PRNewswire/ -- Veritiv Corporation (NYSE: VRTV), a full-service provider of business-to-business products, services and solutions, today announced financial results for the second quarter ended June 30, 2022.

"Double-digit organic sales growth and continued operational excellence contributed to the best performance for any quarter in company history for net income, EPS, Adjusted EBITDA dollars and Adjusted EBITDA margin," said Sal Abbate, Chief Executive Officer.  "The combination of continued sales growth and our cost and price management discipline resulted in record net income of $91 million which was more than three times higher than the second quarter of 2021, while diluted earnings per share increased to a record $6.12."

For the three months ended June 30, 2022, compared to the three months ended June 30, 2021:

For the six months ended June 30, 2022, compared to the six months ended June 30, 2021:

For the three months ended June 30, 2022, net cash provided by operating activities was $68.2 million and free cash flow was $66.0 million. For the six months ended June 30, 2022, net cash provided by operating activities was $62.3 million and free cash flow was $50.7 million.

"During the second quarter, while repurchasing $94.4 million worth of shares under our $200 million Share Repurchase Program, our strong earnings performance drove a record low net leverage ratio of 0.7x," said Steve Smith, Chief Financial Officer.  "Our record low net leverage ratio and strong free cash flow generation provides us with significant optionality to enhance our growth."

Revised 2022 Guidance

Given the strong financial performance so far this year and favorable outlook for the remainder of the year, despite the divestiture of our Canada business, the Company now expects full year 2022 net income to be in the range of $285 to $315 million. Diluted earnings per share is estimated to be in the range of $19.50 to $21.50, based on approximately 14.7 million fully diluted shares outstanding. Adjusted EBITDA is now expected to be in the range of $475 to $505 million. Net cash provided by operating activities and free cash flow are still expected to be approximately $280 million and $250 million, respectively. Capital expenditures are still estimated to be approximately $30 million.

 1Adjusted EBITDA Margin is defined as Adjusted EBITDA as a percentage of net sales.

-----

Veritiv Corporation will host a conference call and webcast today, August 9, 2022, at 9 a.m. (ET) to discuss its second quarter financial results and full year 2022 guidance. To participate, callers within the United States (U.S.) and Canada can dial (888) 330-2469, and international callers can use the following link for international access numbers, https://events.evolveirportal.com/custom/access/2324, both using conference ID number 3047006. Interested parties can also listen online at ir.veritivcorp.com. A replay of the call and webcast will be available online for a limited period of time at ir.veritivcorp.com shortly after the webcast is completed.

Important information regarding U.S. generally accepted accounting principles ("U.S. GAAP") and related reconciliations of non-GAAP financial measures to the most comparable U.S. GAAP measures can be found in the schedules to this press release, which should be thoroughly reviewed.

About Veritiv

Veritiv Corporation (NYSE: VRTV), headquartered in Atlanta and a Fortune 500® company, is a full-service provider of packaging, JanSan and hygiene products, services and solutions. Additionally, Veritiv provides print and publishing products, and logistics and supply chain management solutions. Serving customers in a wide range of industries both in North America and globally, Veritiv has distribution centers throughout the U.S. and Mexico, and team members around the world helping shape the success of its customers.  For more information about Veritiv and its business segments visit www.veritivcorp.com.

Safe Harbor Provision

Certain statements contained in this press release regarding Veritiv Corporation's (the "Company") future operating results, performance, strategy, business plans, prospects and guidance, statements related to the impact of COVID-19 and any other statements not constituting historical fact are "forward-looking statements" subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Where possible, the words "believe," "expect," "anticipate," "continue," "intend," "should," "will," "would," "planned," "estimated," "potential," "goal," "outlook," "may," "predicts," "could," or the negative of such terms, or other comparable expressions, have been used to identify such forward-looking statements. All forward-looking statements reflect only the Company's current beliefs and assumptions with respect to future operating results, performance, business plans, prospects, guidance and other matters, and are based on information currently available to the Company. Accordingly, the statements are subject to significant risks, uncertainties and contingencies, which could cause the Company's actual operating results, performance, business plans, prospects or guidance to differ materially from those expressed in, or implied by, these statements. 

Factors that could cause actual results to differ materially from current expectations include the risks and other factors described under "Risk Factors" and elsewhere in our Annual Report on Form 10-K and in the Company's other publicly available reports filed with the Securities and Exchange Commission ("SEC"). Such risks and other factors, which in some instances are beyond the Company's control, include: adverse impacts of the COVID-19 pandemic; the industry-wide decline in demand for paper and related products; increased competition from existing and non-traditional sources; procurement and other risks in obtaining packaging, facility products and paper from our suppliers for resale to our customers; changes in prices for raw materials; changes in trade policies and regulations; increases in the cost of fuel and third-party freight and the availability of third-party freight providers; the loss of any of our significant customers; inability to realize expected benefits of restructuring plans; adverse developments in general business and economic conditions that could impair our ability to use net operating loss carryforwards and other deferred tax assets; our ability to adequately protect our material intellectual property and other proprietary rights, or to defend successfully against intellectual property infringement claims by third parties; our ability to attract, train and retain highly qualified employees; our pension and health care costs and participation in multi-employer pension, health and welfare plans; the effects of work stoppages, union negotiations and labor disputes; our ability to generate sufficient cash to service our debt; increasing interest rates; our ability to refinance or restructure our debt on reasonable terms and conditions as might be necessary from time to time; our ability to comply with the covenants contained in our debt agreements; costs to comply with laws, rules and regulations, including environmental, health and safety laws, and to satisfy any liability or obligation imposed under such laws; changes in tax laws; adverse results from litigation, governmental investigations or audits, or tax-related proceedings or audits; regulatory changes and judicial rulings impacting our business; the impact of adverse developments in general business and economic conditions as well as conditions in the global capital and credit markets on demand for our products and services, our business including our international operations, and our customers; foreign currency fluctuations; inclement weather, widespread outbreak of an illness, anti-terrorism measures and other disruptions to our supply chain, distribution system and operations; our dependence on a variety of information technology and telecommunications systems and the Internet; our reliance on third-party vendors for various services; cybersecurity risks; and other events of which we are presently unaware or that we currently deem immaterial that may result in unexpected adverse operating results.

The Company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet service providers. This press release is being furnished to the SEC through a Form 8-K. The Company's Quarterly Report on Form 10-Q for the three and six months ended June 30, 2022 to be filed with the SEC may contain updates to the information included in this release.

Financial Statements

VERITIV CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in millions, except per share data, unaudited)












Three Months Ended

June 30,


Six Months Ended

June 30,



2022


2021


2022


2021

Net sales


$     1,820.7


$     1,658.6


$     3,678.8


$     3,217.9

Cost of products sold (exclusive of depreciation and amortization shown separately below)


1,410.9


1,319.0


2,866.3


2,557.1

Distribution expenses


98.2


104.0


210.4


205.5

Selling and administrative expenses


180.7


177.8


368.6


344.2

Depreciation and amortization


11.1


14.3


23.8


28.8

Restructuring charges, net


1.4


5.2


4.1


9.5

Operating income (loss)


118.4


38.3


205.6


72.8

Interest expense, net


4.0


4.5


7.5


9.6

Other (income) expense, net


(6.6)


(1.7)


(7.2)


(2.7)

Income (loss) before income taxes


121.0


35.5


205.3


65.9

Income tax expense (benefit)


29.9


9.1


35.7


18.2

Net income (loss)


$           91.1


$           26.4


$         169.6


$           47.7










Earnings (loss) per share:









Basic


$           6.24


$           1.69


$         11.55


$           3.03

Diluted


$           6.12


$           1.62


$         11.23


$           2.89










Weighted-average shares outstanding:









Basic


14.61


15.58


14.69


15.73

Diluted


14.88


16.30


15.10


16.49

 

VERITIV CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(dollars in millions, except par value, unaudited)








June 30, 2022


December 31, 2021

Assets





Current assets:





Cash and cash equivalents


$                           32.1


$                           49.3

Accounts receivable, less allowances of $29.8 and $34.4, respectively


968.4


1,011.2

Inventories


423.8


484.5

Other current assets


127.5


132.7

Total current assets


1,551.8


1,677.7

Property and equipment (net of accumulated depreciation and amortization
of $321.5 and $332.4, respectively)


135.2


162.9

Goodwill


96.3


99.6

Other intangibles, net


37.8


42.7

Deferred income tax assets


58.8


47.1

Other non-current assets


355.0


408.4

Total assets


$                      2,234.9


$                     2,438.4

Liabilities and shareholders' equity





Current liabilities:





Accounts payable


$                         533.4


$                        561.9

Accrued payroll and benefits


72.2


110.0

Other accrued liabilities


151.5


185.7

Current portion of debt


15.2


16.0

Total current liabilities


772.3


873.6

Long-term debt, net of current portion


398.3


499.7

Defined benefit pension obligations


4.1


7.2

Other non-current liabilities


376.3


422.1

Total liabilities


1,551.0


1,802.6

Commitments and contingencies





Shareholders' equity:





Preferred stock, $0.01 par value, 10.0 million shares authorized, none issued


?


?

Common stock, $0.01 par value, 100.0 million shares authorized; shares
issued - 17.5 million and 17.0 million, respectively; shares outstanding - 14.3
million and 14.6 million, respectively


0.2


0.2

Additional paid-in capital


610.0


633.8

Accumulated earnings (deficit)


312.8


143.2

Accumulated other comprehensive loss


(17.2)


(24.3)

Treasury stock at cost - 3.2 million and 2.4 million shares, respectively


(221.9)


(117.1)

Total shareholders' equity


683.9


635.8

Total liabilities and shareholders' equity


$                      2,234.9


$                     2,438.4

 

VERITIV CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions, unaudited)








Six Months Ended June 30,



2022


2021

Operating activities





Net income (loss)


$                     169.6


$                       47.7

Depreciation and amortization


23.8


28.8

Amortization and write-off of deferred financing fees


0.8


0.7

Net (gains) losses on disposition of assets and sale of a business


(15.3)


(5.6)

Provision for expected credit losses


(0.1)


(0.3)

Deferred income tax provision (benefit)


(11.6)


1.3

Stock-based compensation


5.9


4.7

Other non-cash items, net


(7.0)


1.8

Changes in operating assets and liabilities





Accounts receivable


(51.4)


(36.2)

Inventories


(25.4)


(21.2)

Other current assets


(1.5)


0.4

Accounts payable


23.4


58.9

Accrued payroll and benefits


(31.8)


(13.9)

Other accrued liabilities


(13.9)


(18.6)

Other


(3.2)


1.6

Net cash provided by (used for) operating activities


62.3


50.1

Investing activities





Property and equipment additions


(11.6)


(9.1)

Proceeds from asset sales and sale of a business, net of cash transferred


139.4


11.3

Proceeds from insurance related to property and equipment


3.5


?

Net cash provided by (used for) investing activities


131.3


2.2

Financing activities





Change in book overdrafts


12.9


(6.3)

Borrowings of long-term debt


3,111.5


2,845.1

Repayments of long-term debt


(3,190.9)


(2,909.0)

Payments under right-of-use finance leases


(6.3)


(6.7)

Payments under vendor-based financing arrangements


(3.2)


?

Deferred financing fees


?


(3.3)

Purchase of treasury stock


(104.8)


(50.4)

Impact of tax withholding on share-based compensation


(29.7)


(8.3)

Other


0.3


0.7

Net cash provided by (used for) financing activities


(210.2)


(138.2)

Effect of exchange rate changes on cash


(0.6)


0.0

Net change in cash and cash equivalents


(17.2)


(85.9)

Cash and cash equivalents at beginning of period


49.3


120.6

Cash and cash equivalents at end of period


$                       32.1


$                       34.7

Supplemental cash flow information





Cash paid for income taxes, net of refunds


$                       57.8


$                       26.0

Cash paid for interest


6.4


8.6

Non-cash investing and financing activities





Non-cash additions to property and equipment for right-of-use finance leases
and vendor-based financing arrangements


$                       18.1


$                         0.4

Non-cash additions to other non-current assets for right-of-use operating leases


37.3


24.8

 

Non-GAAP Measures

We supplement our financial information prepared in accordance with U.S. GAAP with certain non-GAAP measures including organic sales (net sales on an average daily sales basis excluding revenue from sold businesses in the prior year period for which there is no comparable revenue in the current year period, and revenue from acquired businesses for a period of 12 months after we complete the acquisition), Adjusted EBITDA (earnings before interest, income taxes, depreciation and amortization, restructuring charges, net, integration and acquisition expenses and other similar charges including any severance costs, costs associated with warehouse and office openings or closings, consolidation, and relocation and other business optimization expenses, stock-based compensation expense, changes in the LIFO reserve, non-restructuring asset impairment charges, non-restructuring severance charges, non-restructuring pension charges (benefits), fair value adjustments related to contingent liabilities assumed in mergers and acquisitions and certain other adjustments), free cash flow and other non-GAAP measures such as the Net Leverage Ratio (calculated as Net Debt to Adjusted EBITDA). We believe investors commonly use Adjusted EBITDA, free cash flow and these other non-GAAP measures as key financial metrics for valuing companies; we also present organic sales to help investors better compare period-over-period results. In addition, the credit agreement governing our Asset-Based Lending Facility (the "ABL Facility") permits us to exclude the foregoing and other charges in calculating "Consolidated EBITDA", as defined in the ABL Facility.

Organic sales, Adjusted EBITDA, free cash flow and these other non-GAAP measures are not alternative measures of financial performance or liquidity under U.S. GAAP. Non-GAAP measures do not have definitions under U.S. GAAP and may be defined differently by, and not be comparable to, similarly titled measures used by other companies. As a result, we consider and evaluate non-GAAP measures in connection with a review of the most directly comparable measure calculated in accordance with U.S. GAAP. We caution investors not to place undue reliance on such non-GAAP measures and to consider them with the most directly comparable U.S. GAAP measures. Organic sales, Adjusted EBITDA, free cash flow and these other non-GAAP measures have limitations as analytical tools and should not be considered in isolation or as a substitute for analyzing our results as reported under U.S. GAAP. Please see the following tables for reconciliations of non-GAAP measures to the most comparable U.S. GAAP measures. 

Table I

VERITIV CORPORATION

RECONCILIATION OF NON-GAAP MEASURES

NET INCOME (LOSS) TO ADJUSTED EBITDA; ADJUSTED EBITDA MARGIN

(in millions, unaudited)








Three Months Ended

June 30,


Six Months Ended

June 30,



2022


2021


2022


2021

Net income (loss)


$         91.1


$         26.4


$      169.6


$         47.7

Interest expense, net


4.0


4.5


7.5


9.6

Income tax expense (benefit)


29.9


9.1


35.7


18.2

Depreciation and amortization


11.1


14.3


23.8


28.8

EBITDA


136.1


54.3


236.6


104.3

Restructuring charges, net


1.4


5.2


4.1


9.5

Facility closure charges, including (gain) loss from asset disposition


(0.3)


(1.5)


(0.9)


(1.2)

Stock-based compensation


3.1


3.5


5.9


4.7

LIFO reserve (decrease) increase


11.8


11.0


22.8


16.1

Non-restructuring severance charges


(0.2)


1.1


1.5


1.9

Non-restructuring pension charges (benefits)


(7.0)


?


(7.0)


?

Other


(8.6)


(0.1)


(7.2)


(2.3)

Adjusted EBITDA


$      136.3


$         73.5


$      255.8


$       133.0










Net sales


$   1,820.7


$   1,658.6


$   3,678.8


$   3,217.9

Adjusted EBITDA as a % of net sales


7.5 %


4.4 %


7.0 %


4.1 %

 

Table I.a.

VERITIV CORPORATION

RECONCILIATION OF NON-GAAP MEASURES

ADJUSTED EBITDA GUIDANCE

(in millions, unaudited)








Forecast for Year Ending December 31, 2022



Low


High

Net income (loss)


$                               285


$                               315

Interest expense, net


15


15

Income tax expense (benefit)


85


90

Depreciation and amortization


50


50

Other reconciling items


40


35

Adjusted EBITDA


$                               475


$                               505

 

Table II

VERITIV CORPORATION

RECONCILIATION OF NON-GAAP MEASURES

FREE CASH FLOW

(in millions, unaudited)








Three Months Ended
June 30, 2022


Six Months Ended
June 30, 2022

Net cash provided by (used for) operating activities


$                                 68.2


$                                 62.3

Less: Capital expenditures


(2.2)


(11.6)

Free cash flow


$                                 66.0


$                                 50.7

 

Table II.a

VERITIV CORPORATION

RECONCILIATION OF NON-GAAP MEASURES

FREE CASH FLOW GUIDANCE

(in millions, unaudited)






Forecast for Year Ending December 31, 2022

Net cash provided by (used for) operating activities


approximately $280

Less: Capital expenditures


approximately ($30)

Free cash flow


approximately $250

 

Table III

VERITIV CORPORATION

RECONCILIATION OF NON-GAAP MEASURES

NET DEBT TO ADJUSTED EBITDA

(in millions, unaudited)




June 30, 2022

Amount drawn on ABL Facility

$                             361.4

Less: Cash and cash equivalents

(32.1)

Net debt

$                             329.3



Last Twelve Months Adjusted EBITDA

$                             465.4



Net debt to Adjusted EBITDA

0.7x




Last Twelve Months


June 30, 2022

Net income (loss)

$                             266.5

Interest expense, net

15.1

Income tax expense (benefit)

70.4

Depreciation and amortization

50.2

EBITDA

402.2

Restructuring charges, net

10.0

Facility closure charges, including (gain) loss from asset disposition

0.4

Stock-based compensation

8.6

LIFO reserve (decrease) increase

50.3

Non-restructuring severance charges

7.4

Non-restructuring pension charges (benefits)

(6.5)

Other

(7.0)

Adjusted EBITDA

$                             465.4

 

Table IV

VERITIV CORPORATION

RECONCILIATION OF NON-GAAP MEASURES

SALES GROWTH TO ORGANIC GROWTH

(in millions, unaudited)












Three Months Ended

June 30,


Six Months Ended

June 30,



2022


2021


2022


2021

Reported sales growth


9.8 %


18.1 %


14.3 %


3.4 %

Daily impact


0.0 %


0.0 %


0.0 %


0.8 %

Sales per day growth


9.8 %


18.1 %


14.3 %


4.2 %

Business divestitures1


8.4 %


0.1 %


4.9 %


0.0 %

Organic sales growth2


18.2 %


18.1 %


19.2 %


4.1 %










Business Days


64


64


127


127

1 Represents the divestitures of the Rollsource business on March 31, 2021 and the Veritiv Canada, Inc. business on May 2, 2022.

2 Some of the amounts do not sum due to rounding.

 

Veritiv Corporation Logo (PRNewsFoto/Veritiv Corporation) (PRNewsfoto/Veritiv Corporation)

SOURCE Veritiv Corporation


These press releases may also interest you

at 12:32
The countdown has begun for Northern Colorado's most exhilarating fitness competition of the year as "Health4Heroes" gears up to host its highly anticipated 3rd Annual Military and First Responder-inspired "Guardian Games & Expo" on Saturday, May 18,...

at 12:06
A Philadelphia jury has returned a $725.5 million verdict against ExxonMobil, finding the company's failure to warn about known health risks of exposure to cancer-causing benzene in its petroleum products was responsible for a former service station...

at 12:05
Be Biopharma, Inc. ("Be Bio"), a company pioneering the discovery and development of Engineered B Cell Medicines (BCMs), today presented results from new preclinical research demonstrating production of active ALP by a BCM, which highlights BCMs as a...

at 11:50
EGLE Therapeutics, a clinical-stage biotechnology company uniquely positioned to advance the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Pejvack Motlagh MD, MSc, as Chief...

at 11:30
WomenHeart: The National Coalition for Women with Heart Disease, in collaboration with Bayer, is proud to announce the launch of the Understanding Her Heart: Women and Cardiovascular Disease initiative. This groundbreaking partnership aims to bolster...

at 11:15
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the publication of results from SLIM LIVER (also known as A5371) in the Annals of Internal Medicine. "The Effect of Open-Label Semaglutide on...



News published on and distributed by: